Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59ec76c1edb74282963745aeca3f96bb |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-202 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-202 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-232 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
filingDate |
2003-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb2607f2014b12d3e55ce2d0ea827042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_899436c397d9d189e84b4a5a1384f296 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f62787259834857eddce7543ee7c99a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b874829ff47e3703ae256ff67bf25d3d |
publicationDate |
2005-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1501493-A1 |
titleOfInvention |
Use of epa and dha in secondary prevention |
abstract |
The invention is directed to the use of the n-3 PUFA EPA and/or DHA in the preparation of an oral medicament for preventing cerebral damage in patients having symptoms of atherosclerosis of arteries supplying the brain. |
priorityDate |
2002-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |